New antiviral drug from Merck could help reduce COVID hospitalizations and deaths

Pharmaceutical giant Merck announced promising results from a study of a new antiviral drug. Molnupiravir reduced COVID hospitalizations or death by 50% in a trial involving 775 volunteers.

[Copyright 2021 NPR]